Medpace

Update in progress

MEDP (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

Medpace Holdings, Inc. provides global pharmaceutical, biotechnology, and medical device clinical development services across North America, Europe, Asia, and beyond, from Phase I to Phase IV. The company offers plan design, central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance, regulatory submissions, and post-marketing support. It also provides bio-analytical lab work, clinical pharmacology, imaging, and ECG reading services. Founded in 1992, based in Cincinnati, Ohio.

Company score

Sentiment: -0.18; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.36; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.64; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.03; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.10; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive